BoneMRI v1.4
K221762MRlguidance B.V. · cleared 2022-11-16 · product code QIH · Radiology
Premarket evidence — what FDA accepted
source quote (p.3)
“BoneMRI is an image processing software that can be used for image enhancement in MRI images.”
source quote (p.8)
“MRIguidance software implements an image enhancement algorithm using convolutional neural network. Original images are enhanced by running them through a cascade of filter banks, where thresholding and scaling operations are applied. Separate neural network-based filters are obtained to assign a Hounsfield Unit (HU) value to a single volume element, based on intensity and contextual information. The parameters of the model were obtained through an algorithm development pipeline.”
source quote (p.5)
“None of the data used in the training dataset was used subsequently in the validation dataset.”
Validation studies (1)
Retrospective clinical
n=73 patients
endpoints: accuracy of 3D bone morphology; radiodensity; radiodensity contrast in BoneMRI and CT images; voxel-by-voxel HUs; standard deviations around these HU values
Reported performance (0 observations)
FDA source did not state a quantitative performance metric — non-reporting is itself the signal.
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).